News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,256 Results
Type
Article (728)
Company Profile (6)
Press Release (21522)
Section
Business (10753)
Career Advice (22)
Deals (2000)
Drug Development (2080)
Employer Resources (9)
FDA (306)
Job Trends (789)
News (14006)
Policy (722)
Tag
Academia (76)
Accelerated approval (3)
Allergies (6)
Alliances (653)
ALS (7)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (5)
Approvals (346)
Artificial intelligence (9)
Autoimmune disease (5)
Automation (1)
Bankruptcy (4)
Best Places to Work (772)
Biosimilars (6)
Biotechnology (8)
Bladder cancer (10)
Breast cancer (34)
Cancer (234)
Cardiovascular disease (16)
Career advice (23)
CAR-T (8)
Cell therapy (14)
Cervical cancer (4)
Clinical research (1975)
Collaboration (30)
Compensation (13)
COVID-19 (44)
CRISPR (2)
C-suite (9)
Cystic fibrosis (3)
Data (301)
Depression (3)
Diabetes (34)
Diagnostics (244)
Digital health (1)
Diversity, equity & inclusion (4)
Drug discovery (9)
Drug pricing (2)
Duchenne muscular dystrophy (6)
Earnings (10087)
Editorial (1)
Employer branding (2)
Employer resources (9)
Events (2453)
Executive appointments (7)
FDA (537)
Funding (26)
Gene editing (9)
Generative AI (1)
Gene therapy (15)
GLP-1 (41)
Government (102)
Guidances (108)
Healthcare (802)
HIV (1)
IgA nephropathy (7)
Immunology and inflammation (5)
Immuno-oncology (1)
Indications (7)
Infectious disease (51)
Inflammatory bowel disease (15)
Influenza (2)
Intellectual property (58)
Interviews (6)
IPO (1750)
Job creations (36)
Job search strategy (13)
Kidney cancer (1)
Labor market (2)
Layoffs (10)
Legal (82)
Liver cancer (5)
Lung cancer (40)
Lymphoma (21)
Machine learning (1)
Management (4)
Manufacturing (12)
MASH (12)
Medical device (665)
Medtech (669)
Mergers & acquisitions (286)
Metabolic disorders (64)
Multiple sclerosis (14)
NASH (1)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (101)
NextGen: Class of 2026 (333)
Non-profit (142)
Obesity (16)
Opinion (1)
Ovarian cancer (5)
Pain (8)
Pancreatic cancer (13)
Parkinson's disease (9)
Partnered (2)
Patents (114)
Patient recruitment (16)
Peanut (4)
People (806)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (499)
Phase 2 (868)
Phase 3 (826)
Pipeline (573)
Postmarket research (35)
Preclinical (228)
Press Release (1)
Prostate cancer (20)
Radiopharmaceuticals (4)
Rare diseases (18)
Real estate (74)
Recruiting (5)
Regulatory (723)
Reports (2)
Research institute (65)
Resumes & cover letters (4)
Rett syndrome (1)
RSV (5)
Schizophrenia (8)
Series A (4)
Series B (2)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (8)
Startups (26)
Stomach cancer (1)
Vaccines (14)
Weight loss (12)
Women's health (3)
Date
Today (2)
Last 7 days (26)
Last 30 days (81)
Last 365 days (1642)
2026 (105)
2025 (1663)
2024 (1651)
2023 (1902)
2022 (2200)
2021 (2018)
2020 (1711)
2019 (5195)
2018 (961)
2017 (621)
2016 (367)
2015 (535)
2014 (405)
2013 (192)
2012 (254)
2011 (308)
2010 (390)
Location
Africa (9)
Alabama (3)
Arizona (8)
Asia (1534)
Australia (131)
California (544)
Canada (228)
China (37)
Colorado (29)
Connecticut (35)
Delaware (26)
Europe (2594)
Florida (62)
Georgia (19)
Illinois (47)
India (3)
Indiana (37)
Japan (19)
Kansas (3)
Kentucky (2)
Louisiana (5)
Maine (5)
Maryland (41)
Massachusetts (341)
Michigan (22)
Minnesota (27)
Missouri (4)
Nevada (4)
New Hampshire (5)
New Jersey (189)
New York (175)
North Carolina (95)
Northern California (249)
Ohio (17)
Pennsylvania (102)
South America (34)
South Carolina (1)
Southern California (248)
Tennessee (2)
Texas (67)
United States (1954)
Utah (13)
Virginia (17)
Washington D.C. (4)
Washington State (35)
Wisconsin (5)
22,256 Results for "204".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204
February 3, 2026
·
1 min read
Press Releases
U.S. FDA Grants RMAT Designation to ECT204, an ARTEMIS® CAR (AbTCR) T-Cell Therapy for Advanced Hepatocellular Carcinoma
January 12, 2026
·
4 min read
Press Releases
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
December 17, 2025
·
5 min read
Press Releases
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
November 13, 2025
·
3 min read
Press Releases
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
November 26, 2025
·
5 min read
Press Releases
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204
August 18, 2025
·
4 min read
Press Releases
Telix Reports $204M Revenue, Up 63% YOY
July 22, 2025
·
14 min read
Press Releases
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204
September 5, 2025
·
6 min read
Press Releases
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
October 1, 2025
·
6 min read
Press Releases
Antibody Discovery Market Size to Surpass USD 20.4 Bn by 2034 Fueled by Precision Medicine and Biotech Innovation
July 17, 2025
·
1 min read
1 of 2,226
Next
